Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
John C Eppensteiner
Assistant Professor of Emergency Medicine
Emergency Medicine
john.eppensteiner@duke.edu
https://orcid.org/0000-0003-4450-5548
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Duke Appointments & Affiliations
Previous Duke Appointments & Affiliations
Professional Training & Employment
global-scholarship {hide_children: true, active: false, enabled: false}
Global Scholarship
keywords {hide_children: true, active: false, enabled: true}
Keywords
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
scholarly-works {hide_children: true, active: false, enabled: true}
Scholarly Works
Featured Works
Conferences
Journal articles
teaching-mentoring {hide_children: true, active: false, enabled: false}
Teaching & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
Sc2i Competitive Renewal
Research
Investigator ·
Awarded by Henry M. Jackson Foundation ·
2021 - 2027
Elucidating and mitigating the effects of Damage Associated Molecular Patterns (DAMPs) released following severe traumatic injury.
Research
Co Investigator ·
Awarded by Department of Defense ·
2024 - 2026
A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19
Clinical Trial
Principal Investigator ·
Awarded by Regeneron Pharmaceuticals, Inc. ·
2020 - 2026
A PHASE 2 STUDY TO ASSESS THE VIROLOGIC EFFICACY OF REGN10933+REGN10987 ACROSS DIFFERENT DOSE REGIMENS IN OUTPATIENTS WITH SARS-CoV-2 INFECTION
Clinical Trial
Principal Investigator ·
Awarded by Regeneron Pharmaceuticals, Inc. ·
2020 - 2023
Sc2i
Research
Co Investigator ·
Awarded by Henry M. Jackson Foundation ·
2020 - 2021
Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease
Clinical Trial
Principal Investigator ·
Awarded by Vanderbilt University Medical Center ·
2020 - 2020
SC2i
Research
Fellow ·
Awarded by Henry M. Jackson Foundation ·
2014 - 2020
https://orcid.org/0000-0003-4450-5548